Caxton Associates (New York)’s Innovex International INVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$211K Sell
15,087
-5,905
-28% -$88.5K 0.01% 444
2024
Q3
$308K Buy
20,992
+3,427
+20% +$55K 0.01% 433
2024
Q2
$327K Buy
+17,565
New +$341K 0.01% 396
2024
Q1
Sell
-10,133
Closed -$236K 598
2023
Q4
$236K Buy
+10,133
New +$238K 0.01% 414
2023
Q2
Sell
-24,120
Closed -$692K 676
2023
Q1
$692K Buy
24,120
+9,726
+68% +$288K 0.1% 206
2022
Q4
$391K Buy
+14,394
New +$343K 0.03% 291
2022
Q1
Sell
-42,121
Closed -$829K 748
2021
Q4
$829K Buy
42,121
+7,049
+20% +$155K 0.08% 154
2021
Q3
$883K Buy
35,072
+7,773
+28% +$207K 0.1% 115
2021
Q2
$924K Buy
27,299
+14,656
+116% +$493K 0.1% 82
2021
Q1
$420K Buy
+12,643
New +$434K 0.04% 196

Other funds holding INVX

Caxton Associates (New York)'s INVX Position: Q4 2024 in Review

Caxton Associates (New York) reduced its Innovex International (INVX) stake by 28% in Q4 2024, selling an estimated $88.5K and leaving 15,087 shares worth $211K. The position accounts for 0.01% of the portfolio, ranked #444.

Caxton Associates (New York) first reported a position in INVX in Q1 2021 and has held it in 10 quarters since. The position peaked at $924K in Q2 2021. 168 funds tracked by Wall St. Rank hold INVX as of Q4 2024.

  • Caxton Associates (New York) held 15,087 shares of Innovex International worth $211K as of Q4 2024.
  • Caxton Associates (New York) sold 5,905 Innovex International shares in Q4 2024, an estimated $88.5K.
  • Innovex International made up 0.01% of Caxton Associates (New York)'s portfolio in Q4 2024, its #444 holding.
  • Caxton Associates (New York) first reported a position in Innovex International in Q1 2021 and has held it in 10 quarters since.
  • Caxton Associates (New York)'s Innovex International position peaked at $924K in Q2 2021.
  • 168 funds tracked by Wall St. Rank held Innovex International as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.